Roche to Invest $1.18 B in Foundation Medicine to Boost Cancer Efforts
The deal will help Roche develop combination therapies and identify cancer patients more accurately.
Won’t Follow M&A Trend – Says Smith & Nephew CEO
Olivier Bohuon says he is not a fan of the concept of big is beautiful, and adds that there’s not much innovation occurring in hip implants.
The Key to Successfully Selling Medical Devices in China and Japan – Good Distributors
One of the best ways for small and mid sized Western device firms to take advantage of these growing markets is to conclude agreements with reputable, trustworthy, and well connected medical device distributors located there.
Humanitarian Use Devices and Third-Party Reimbursement
Payers often apply the same evidence standards to Humanitarian Use Devices as other devices and demand high quality clinical trials, following an approach similar to the PMA or 510(k) regulatory pathways, where payers frequently impose a higher evidence standard than FDA. But how flexible are payers in setting their evidence requirements? Will they consider HUDs as investigational?
Wake Up, Western Medical Device Makers!
While getting rid of the medical device tax is a key issue for many Western device manufacturers, perhaps a more important issue is global competition.
5 Questions About the Medical Device Tax, and Its Potential for Repeal
Will the device tax be repealed? What are its implications under the 114th Congress? This primer provides some answers.
HCT/P Regulation and Third-Party Reimbursement
Comprehensive and unwieldy payer policies for wound care, the tiered system of FDA regulation of human cells, tissues, and cellular and tissue-based products, and the use of brand specific names in HCPCS coding have created a challenging reimbursement environment.
China’s Rapidly Expanding Cancer Market
Here are 5 strategies that Western medical device companies need to adopt to tap into the growing Chinese market for devices and diagnostics.
“Med-tech Innovation Happening at Speed of Technology, not Healthcare”
In this interview Brian Williams, Director, Healthcare Strategy and Innovation at PwC, talks about the impact of med-tech trends such as outcomes based reimbursement, lessons learned in emerging markets, and impact of the device tax.
3 Tips for Building Strong Business Relationships in Asia
A good understanding of and appreciation for Asian cultural traits is essential to building strong relationships with Asian executives. Business in Asia will be more likely to thrive if a Western medical device executive is able to overcome these challenges.
